CardioMag to sell MCG in the U.S. following FDA approval
CardioMag Imaging Inc. of Schenectady, N.Y., has received clearance from the FDA to market and sell the magnetocardiograph (MCG), a cardiac device which can detect the magnetic field generated by a person's heart.
According to CardioMag, six hospitals are already using the device to study, for instance, the ability of MCG to detect coronary artery disease. One of the institutes, Cedars-Sinai Medical Center in Los Angeles, Calif., is conducting research with the device in its non-invasive cardiology lab.
An MCG procedure takes less than 10 minutes to perform, does not require injections or radiation and generates a thousand images per heartbeat, said CardioMag.
Devices are currently installed in the Europe and Asia.
According to CardioMag, six hospitals are already using the device to study, for instance, the ability of MCG to detect coronary artery disease. One of the institutes, Cedars-Sinai Medical Center in Los Angeles, Calif., is conducting research with the device in its non-invasive cardiology lab.
An MCG procedure takes less than 10 minutes to perform, does not require injections or radiation and generates a thousand images per heartbeat, said CardioMag.
Devices are currently installed in the Europe and Asia.